abstract |
The present invention relates to the use of VLDLR for the prevention, diagnosis or treatment of colorectal cancer and rectal cancer, wherein VLDLR expression is down-regulated in CRC, and such low expression is regulated by miR-200c, thus overexpressing VLDLR , miR-200c inhibition of colon cancer and rectal cancer can be applied to the treatment is effective. |